Atrophin‐1 Function and Dysfunction in Dentatorubral–Pallidoluysian Atrophy
Sign Up to like & getrecommendations! Published in 2023 at "Movement Disorders"
DOI: 10.1002/mds.29355
Abstract: Dentatorubral–pallidoluysian atrophy (DRPLA) is a rare, incurable genetic disease that belongs to the group of polyglutamine (polyQ) diseases. DRPLA is the most common in the Japanese population; however, its global prevalence is also increasing due… read more here.
Keywords: dysfunction; pallidoluysian atrophy; atrophin function; dentatorubral pallidoluysian ... See more keywords
The neostriatum in polyglutamine diseases: preferential decreases in large neurons in dentatorubral‐pallidoluysian atrophy and Machado‐Joseph disease and in small neurons in Huntington disease
Sign Up to like & getrecommendations! Published in 2022 at "Neuropathology"
DOI: 10.1111/neup.12811
Abstract: The presence of polyglutamine‐immunoreactive deposits in neurons of the neostriatum has been reported in dentatorubral‐pallidoluysian atrophy (DRPLA), Machado‐Joseph disease (MJD), and Huntington disease (HD). However, among these diseases, precise quantitative investigations on neurons have been… read more here.
Keywords: pallidoluysian atrophy; machado joseph; disease; polyglutamine ... See more keywords
Successful Treatment with Olanzapine of Psychosis in Dentatorubral-pallidoluysian Atrophy: A Case Report
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Psychopharmacology and Neuroscience"
DOI: 10.9758/cpn.2018.16.2.221
Abstract: Patients with dentatorubral-pallidoluysian atrophy occasionally elicit psychosis. So far, one study reported first generation antipsychotics drugs may provide an effective treatment; however, there is no literature on the benefits of second generation antipsychotics. We report… read more here.
Keywords: dentatorubral pallidoluysian; treatment; pallidoluysian atrophy; psychosis dentatorubral ... See more keywords